185 related articles for article (PubMed ID: 4723812)
1. Studies of carbohydrate and lipid metabolism in women developing hypertension on oral contraceptives.
Mason B; Oakley N; Wynn V
Br Med J; 1973 Aug; 3(5875):317-20. PubMed ID: 4723812
[TBL] [Abstract][Full Text] [Related]
2. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced hypertension: pathogenesis and management.
Stokes GS
Drugs; 1976; 12(3):222-30. PubMed ID: 185040
[TBL] [Abstract][Full Text] [Related]
4. Hypertension and oral contraceptives.
Oparil S
J Cardiovasc Med; 1981 Apr; 6(4):381, 384-7. PubMed ID: 12263383
[TBL] [Abstract][Full Text] [Related]
5. Relationship between levels of blood lipids, vitamins C, A, and E, serum copper compounds, and urinary excretions of tryptophan metabolites in women taking oral contraceptive therapy.
Horwitt MK; Harvey CC; Dahm CH
Am J Clin Nutr; 1975 Apr; 28(4):403-12. PubMed ID: 1119436
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure and contraceptive use.
Khaw KT; Peart WS
Br Med J (Clin Res Ed); 1982 Aug; 285(6339):403-7. PubMed ID: 6809102
[TBL] [Abstract][Full Text] [Related]
7. Myocardial infarction in young women with special reference to oral contraceptive practice.
Mann JI; Vessey MP; Thorogood M; Doll SR
Br Med J; 1975 May; 2(5965):241-5. PubMed ID: 1169093
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
[TBL] [Abstract][Full Text] [Related]
9. Serum-lipids in women on oral contraceptives.
Stokes T; Wynn V
Lancet; 1971 Sep; 2(7726):677-80. PubMed ID: 4105711
[No Abstract] [Full Text] [Related]
10. [Clinical course and pathogenesis of oral contraceptive hypertension (author's transl)].
Girndt J; Scheler F
Med Klin; 1977 Oct; 72(41):1680-4. PubMed ID: 916953
[TBL] [Abstract][Full Text] [Related]
11. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
12. [Effect of hormonal contraceptives on blood pressure following pregnancy-induced hypertension].
Meinel H; Ihle R; Laschinski M
Zentralbl Gynakol; 1987; 109(8):527-31. PubMed ID: 3604495
[TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin II analog on blood pressure, renin and aldosterone in women on oral contraceptives and toxemia.
Saruta T; Nakamura R; Nagahama S; Suzuki H; Kondo K
Gynecol Obstet Invest; 1981; 12(1):11-20. PubMed ID: 7019015
[TBL] [Abstract][Full Text] [Related]
14. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
[TBL] [Abstract][Full Text] [Related]
15. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
16. Elevated prolactin levels in oral contraceptive pill-related hypertension.
Lehtovirta P; Ranta T; Seppälä M
Fertil Steril; 1981 Apr; 35(4):403-5. PubMed ID: 6783445
[TBL] [Abstract][Full Text] [Related]
17. [Oral contraceptives and arterial hypertension].
Pinheiro RL; da Costa JN
Rev Port Cardiol; 1988; 7(3):333-43. PubMed ID: 3078732
[TBL] [Abstract][Full Text] [Related]
18. Hypertension induced by pregnancy, oral contraceptives, and postmenopausal replacement therapy.
Kaplan NM
Cardiol Clin; 1988 Nov; 6(4):475-82. PubMed ID: 3067841
[TBL] [Abstract][Full Text] [Related]
19. Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2.
Visser J; Snel M; Van Vliet HA
Cochrane Database Syst Rev; 2006 Oct; (4):CD003990. PubMed ID: 17054193
[TBL] [Abstract][Full Text] [Related]
20. Hypertension and oral contraception.
Smith RW
Trans Pac Coast Obstet Gynecol Soc; 1971; 39(0):50-5. PubMed ID: 5164822
[No Abstract] [Full Text] [Related]
[Next] [New Search]
